Table 3.
Antibiotic Susceptibility of the Isolated Bacteria Against Ten Antibiotics (Interpretation by Inhibition Zone)
| Antibiotic | Inhibition Zone (mm) | No. of Isolates | % | Interpretation |
|---|---|---|---|---|
| Tetracycline (TE) (30 mg) | <11 | 18 | 37.5 | Resistant |
| 12–14 | 15 | 31.25 | Intermediate sensitive | |
| >15 | 15 | 31.25 | Sensitive | |
| Ciprofloxacin (CIP) (5 mg) | <15 | 42 | 87.5 | Resistant |
| 16–20 | 3 | 6.25 | Intermediate sensitive | |
| >21 | 3 | 6.25 | Sensitive | |
| Vancomycin (VA) (30 mg) | <9 | 3 | 6.25 | Resistant |
| 10–11 | 24 | 50 | Intermediate sensitive | |
| >12 | 21 | 43.75 | Sensitive | |
| Erythromycin (E) (15 mg) | <13 | 39 | 81.25 | Resistant |
| 14–22 | – | 0 | Intermediate sensitive | |
| >23 | 9 | 18.75 | Sensitive | |
| Ceftriaxone (CRO) (30 mg) | <13 | 24 | 50 | Resistant |
| 14–20 | 15 | 31.25 | Intermediate sensitive | |
| >21 | 9 | 18.75 | Sensitive | |
| Levofloxacin (LEV) (5 mg) | <13 | 9 | 18.75 | Resistant |
| 14–16 | 30 | 62.5 | Intermediate sensitive | |
| >17 | 9 | 18.75 | Sensitive | |
| Ofloxacin (OFX) (5 mg) | <12 | 39 | 81.25 | Resistant |
| 13–16 | 3 | 6.25 | Intermediate sensitive | |
| >17 | 6 | 12.5 | Sensitive | |
| Ampicillin (AM) (10 mg) | <13 | 36 | 75 | Resistant |
| 14–16 | 9 | 18.75 | Intermediate sensitive | |
| >17 | 3 | 6.25 | Sensitive | |
| Cefoxitin (FOX) (30 mg) | <21 | 42 | 87.5 | Resistant |
| 21–22 | 3 | 6.25 | Intermediate sensitive | |
| >22 | 3 | 6.25 | Sensitive | |
| Linezolid (LZD) (30 mg) | <20 | – | 0 | Resistant |
| 21–22 | 12 | 25 | Intermediate sensitive | |
| >23 | 36 | 75 | Sensitive |